Pfizer Market Cap 2006-2018 | PFE

Pfizer market cap history and chart from 2006 to 2018. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. Pfizer market cap as of April 24, 2019 is $234.66B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $234.662B $53.647B
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Pfizer's Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $375.338B 17.02
Merck (MRK) United States $201.136B 17.19
Novartis AG (NVS) Switzerland $175.329B 14.91
Eli Lilly (LLY) United States $121.698B 21.13
Novo Nordisk (NVO) Denmark $118.902B 19.23
AbbVie (ABBV) United States $116.030B 9.94
Sanofi (SNY) France $104.612B 12.91
GlaxoSmithKline (GSK) United Kingdom $99.770B 13.10
AstraZeneca (AZN) United Kingdom $97.998B 11.18
Bristol-Myers Squibb (BMY) United States $74.051B 11.39